Infection and Immunity · 1981 · 20 citations · 17 references
Life SciencesImmunologyMicrobiologyClinical ImmunologyDiagnostic MicrobiologyImmunology Of Infectious DiseasesAntibody CharacterizationBacterial ImmunologyHumoral ImmunityPolysaccharide PropertiesPolysaccharide StructureAntibodiesBacterial PolysaccharidesCapsular PolysaccharidesMonosaccharide ReactivityPolysaccharide Antigen ChemistryPolysaccharide CharacterizationSerological DetectionUronic Acid Content
The chemical composition and immunochemical characterization of the four cross-reactive pneumococcal capsular polysaccharides within group 9 (types 9N, 9A, 9L, and 9V) were investigated. Their serological reactions were studied by using unabsorbed antisera prepared by immunizing rabbits with pneumococci of each of the four group 9 capsular polysaccharide types. Type 9A antiserum showed the most extensive cross-reactions with the four group 9 polysaccharides. Absorption with type 9N, 9L, or 9V polysaccharide removed 63, 96, or 87%, respectively, of the heterologous antibodies from the type 9A antiserum. All four of the group 9 polysaccharides contained glucose, N-acetylmannosamine, and glucuronic acid. In addition, types 9N and 9L had N-acetylglucosamine, and types 9A, 9L, and 9V contained galactose. Reduction of the uronic acid residues of the type 9 polysaccharides removed most of their homologous and much of their heterologous reactivities, indicating an important role for the uronic acid component in their antigenicity. The four group 9 polysaccharide preparations had comparable molecular sizes and only traces of protein and nucleic acid. Further studies to evaluate the most protective type among the group 9 strains to be included in the current pneumococcal vaccine are discussed.
17